Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials

Cardiotoxicity of anthracycline agents for the treatment of cancer: Systematic review and meta-analysis of randomised controlled trials

Show other versions (1)

<p>Abstract</p> <p>Background</p> <p>We conducted a systematic review and meta-analysis to clarify the risk of early and late cardiotoxicity of anthracycline agents in patients treated for breast or ovarian cancer, lymphoma, myeloma or sarcoma.</p> <p>Method...

Full description

Bibliographic Details
Main Authors:	Verrill Mark, Levitt Gill, Plummer Christopher J, Cornelius Victoria R, Smith Lesley A, Canney Peter, Jones Alison
Format:	Article
Language:	English
Published:	BMC 2010-06-01
Series:	BMC Cancer
Online Access:	http://www.biomedcentral.com/1471-2407/10/337

Similar Items

Cardiotoxicity of anthracycline agents for the treatment of cancer: systematic review and meta-analysis of randomised controlled trials
by: Lesley, A. Smith, et al.
Published: (2010)

Anthracycline Cardiotoxicity
by: Umberto Campia, MD, MSc, et al.
Published: (2020-06-01)

Cardiotoxicity of Anthracyclines
by: Daniela Cardinale, et al.
Published: (2020-03-01)

Assessing cardiotoxicity in randomised trials of anthracycline in cancer patients
by: Kerr, Amanda J.
Published: (2015)

Anthracycline-Induced Cardiotoxicity
by: Jennifer E. Liu, MD
Published: (2020-03-01)

Anthracycline-Induced Cardiotoxicity
by: Radomír Hrdina, et al.
Published: (2000-01-01)

Dexrazoxane in anthracycline cardiotoxicity
by: Abhijit S Nair
Published: (2017-01-01)

The role of iron in anthracycline cardiotoxicity
by: Elena eGammella, et al.
Published: (2014-02-01)

Updates in Anthracycline-Mediated Cardiotoxicity
by: Canan G. Nebigil, et al.
Published: (2018-11-01)

Candidate Gene Association Studies of Anthracycline-induced Cardiotoxicity: A Systematic Review and Meta-analysis
by: Siew Lian Leong, et al.
Published: (2017-02-01)

Review on the pathophysiology of anthracycline-induced cardiotoxicity
by: Tiago Alexandre de Oliveira Valente
Published: (2019)

Cardiotoxicity in anthracycline therapy: Prevention strategies
by: Margarida Cruz, et al.
Published: (2016-06-01)

Risk Factors for Anthracycline-Induced Cardiotoxicity
by: Shuo Qiu, et al.
Published: (2021-09-01)

Protective Role of Enalapril in Anthracycline-Induced Cardiotoxicity: A Systematic Review
by: Yili Zhang, et al.
Published: (2020-05-01)

Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity
by: Hugh Montgomery, et al.
Published: (2009-01-01)

The genetics of anthracycline-induced cardiotoxicity in cancer patients
by: Naidoo, Horacia
Published: (2018)

POSSIBILITY OF DRUG PREVENTION ANTHRACYCLINE-INDUCED CARDIOTOXICITY
by: V. I. Chernov, et al.
Published: (2016-02-01)

Epigenetic Changes Associated With Anthracycline‐Induced Cardiotoxicity
by: Marwa Tantawy, et al.
Published: (2021-01-01)

Detection of anthracycline induced cardiotoxicity by cardiac biomarkers
Published: (2020-11-01)

Anthracycline-induced cardiotoxicity : the role of proteolytic pathways
by: Sishi, Balindiwe J. N. (Balindiwe Jennifer Nonkosazana)
Published: (2012)

Effect of traditional Chinese medicine on anthracycline-induced cardiotoxicity in animal models: A systematic review and meta-analysis
by: Xiaoguang Lu, et al.
Published: (2021-01-01)

Anthracycline-associated cardiotoxicity in adults: systematic review on the cardioprotective role of beta-blockers
by: Roberto Ramos Barbosa, et al.

Efficacy of Physical Exercise to Offset Anthracycline‐Induced Cardiotoxicity: A Systematic Review and Meta‐Analysis of Clinical and Preclinical Studies
by: Willeke R. Naaktgeboren, et al.
Published: (2021-09-01)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
by: Ariane V.S. Macedo, MD, MSc, et al.
Published: (2019-09-01)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
by: Neha Bansal, et al.
Published: (2019-12-01)

Detection of Subclinical Anthracyclines' Cardiotoxicity in Children with Solid Tumor
by: Hui-Min Hu, et al.
Published: (2018-01-01)

Mechanisms of Anthracycline-Induced Cardiotoxicity: Is Mitochondrial Dysfunction the Answer?
by: Alessandra Murabito, et al.
Published: (2020-03-01)

MODERN VIEW ON CARDIOTOXICITY OF CHEMOTHERAPEUTICS IN ONCOLOGY INCLUDING ANTHRACYCLINES
by: G. E. Gendlin, et al.
Published: (2017-03-01)

The role of the Tei index in assessing for cardiotoxicity from anthracycline chemotherapy: a systematic review
by: Sadie Bennett, et al.
Published: (2021-05-01)

Cardiovascular complications in patients with cancer: focus on anthracycline-induced cardiotoxicity
by: I. T. Murkamilov, et al.
Published: (2021-03-01)

Baseline global longitudinal strain predictive of anthracycline-induced cardiotoxicity
by: Raquel Araujo-Gutierrez, et al.
Published: (2021-01-01)

Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients
by: Elys María Pedraza-Rodríguez, et al.
Published: (2020-01-01)

Detection of subclinical anthracycline induced cardiotoxicity in breast cancer survivors
by: Preety Negi, et al.
Published: (2014-01-01)

The cardioprotective effects of probucol against Anthracycline and Trastuzumab mediated cardiotoxicity
by: Walker, Jonathan Robert
Published: (2010)

The cardioprotective effects of probucol against Anthracycline and Trastuzumab mediated cardiotoxicity
by: Walker, Jonathan Robert
Published: (2010)

Modeling anthracycline-induced cardiotoxicity with patient-specific iPSCs
by: Haupt, Luis Peter
Published: (2018)

Factors associated with anthracycline-induced cardiotoxicity in breast cancer patients
by: Elys María Pedraza-Rodríguez, et al.
Published: (2020-01-01)

Beta-blockers for the primary prevention of anthracycline-induced cardiotoxicity: a meta-analysis of randomized controlled trials
by: Yingxu Ma, et al.
Published: (2019-04-01)

Protects Against Anthracycline-Induced Cardiotoxicity in Early Breast Cancer Patients
by: Wei Hao MD, et al.
Published: (2020-07-01)

Exercise Attenuates Cardiotoxicity of Anthracycline Chemotherapy Measured by Global Longitudinal Strain
by: Benedict T. Costello, MBBS, PhD, et al.
Published: (2019-12-01)

Cannot write session to /tmp/vufind_sessions/sess_1jjtjf5904idil2pmk0pj97h26